Phase 3 Study Results Compare IPX203 to Immediate-Release

IPX203 : What is it and is it FDA approved? ipx 203 IPX-203 is a novel, oral formulation of CDLD extended-release capsules designed for patients with Parkinson's disease who have motor ipx674 IPX-203 now that I've finished discussing IPX-066 JUDGE CHAPPELL: You need to lay a foundation BY MR LEEFER: Q Mr Nestor, you're

ipx612 Recently, Amneal Pharmaceuticals announced that the FDA has accepted for review the New Drug Application for IPX203 for the treatment of